Podocyte Effacement Closely Links to suPAR Levels at Time of Posttransplantation Focal Segmental Glomerulosclerosis Occurrence and Improves With Therapy
Author(s) -
Nada Alachkar,
Changli Wei,
Lois J. Arend,
Annette M. Jackson,
Lorraine C. Racusen,
Alessia Fori,
George W. Burke,
Hamid Rabb,
Kavita Kakkad,
Jochen Reiser,
Michelle M. Estrella
Publication year - 2013
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e31829eda4f
Subject(s) - supar , focal segmental glomerulosclerosis , podocyte , medicine , glomerulosclerosis , glomerulonephritis , proteinuria , receptor , kidney , urokinase receptor
Focal segmental glomerulosclerosis (FSGS) recurs after kidney transplantation in more than 30% of cases and can lead to allograft loss. Serum soluble urokinase-type plasminogen activator receptor (suPAR) is implicated in the pathogenesis of native and recurrent FSGS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom